Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02106091
Title Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Affimed GmbH
Age Groups: adult | senior
Covered Countries USA | DEU

No variant requirements are available.